ROOT OF SKIN™ Skincare Products Sell Out in Tenth Consecutive Appearance on QVC Japan

Date: Oct 15, 2019

IRVINE, Calif. – October 15, 2019 – AIVITA Biomedical, Inc., a biotech company specializing in innovative stem cell applications, announced today that the Company’s ROOT of SKIN™ line of rejuvenating skincare products sold out in its tenth appearance on the Japanese home shopping channel QVC Japan.

ROOT of SKIN™ is AIVITA’s proprietary skincare line for skin rejuvenation, made possible through the same proprietary knowledge and expertise used to develop its cutting-edge stem cell therapies. SourceCode Technology™, the proprietary actives complex in ROOT of SKIN™, contains the complete set of factors and supporting biological components present in young, healthy skin.

AIVITA Biomedical uses 100% of the proceeds from ROOT of SKIN™ sales to support the treatment of women with ovarian cancer.

“Outstanding market traction, a product that truly works, and a benevolent use of proceeds,” said Hans Keirstead, AIVITA’s Chief Executive Officer. “This sets the stage for global expansion of our ROOT of SKIN™ product line.”

About ROOT OF SKIN

ROOT of SKIN™ is a rejuvenating line of skincare products fueled by an unrelenting pursuit for advancements in life-changing and life-saving treatments. Harnessing breakthroughs in stem cell therapy, AIVITA Biomedical developed a technology that does more than just boost regeneration. The patented actives complex SourceCode Technology™ renews, repairs and protects, just as your skin did at its youngest and healthiest stage. Rich with every biological component healthy skin needs for development, and free of any unnecessary ingredients. All proceeds support treatment of women with ovarian cancer.

About AIVITA Biomedical

AIVITA Biomedical is a privately held company engaged in the advancement of commercial and clinical-stage programs utilizing curative and regenerative medicines. Founded in 2016 by pioneers in the stem cell industry, AIVITA Biomedical utilizes its expertise in stem cell growth and directed, high-purity differentiation to enable safe, efficient and economical manufacturing systems which support its therapeutic pipeline and commercial line of skin care products.

###